Concerning the adaptive immune response markers following this short-term treatment with AZT in the mdx mice the reduction of the CD8 and CD4 T-cell transcripts did not reach statistical significance (Fig. 4a ).
← all excerpts
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
1
—
—